Disc Medicine, Inc.
IRON
$42.17
$1.172.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -24.93% | -88.35% | -65.25% | -18.30% | -109.70% |
| Total Depreciation and Amortization | -64.00% | -56.00% | 340.00% | 4.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 341.90% | 38.60% | 27.56% | 279.06% | 123.21% |
| Change in Net Operating Assets | -109.54% | 39.55% | 2,024.48% | 21.29% | 34.98% |
| Cash from Operations | -54.94% | -132.22% | -20.98% | 5.26% | -84.13% |
| Capital Expenditure | -14,866.67% | 117.78% | 125.00% | -131.03% | 75.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -47,433.33% | -157,877.78% | -1,831,141.67% | -131.03% | 75.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -84.51% | -17.76% | 19.87% | -67.58% | -94.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 271.19% | -7.39% | 12.57% | -79.43% | -94.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.99% | -1,146.64% | -143.90% | -142.49% | -107.22% |